These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 973967)

  • 21. Phenylbutazone plasma binding: effects of salicylic acid, indomethacin, and dicloxacillin.
    Quijano R; Kongyingyoes B; Thithapandha A
    Proc Soc Exp Biol Med; 1979 Dec; 162(3):442-4. PubMed ID: 515026
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of age and sex on the plasma binding of acidic and basic drugs.
    Verbeeck RK; Cardinal JA; Wallace SM
    Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protein binding of salicylates in rheumatoid arthritis].
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Pourel J; Faure G; Martin J; Gaucher A
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):447-52. PubMed ID: 7112023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein binding of salicylate in cutaneous hepatic porphyria.
    Steele WH; Boobis SW; Moore MR; Goldberg A; Brodie MJ; Summer DJ
    Eur J Clin Pharmacol; 1978 Jun; 13(4):309-13. PubMed ID: 668790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of phenylbutazone on the plasma protein binding, plasma concentration and urinary excretion of salicylic acid in rabbits (author's transl)].
    Kaneo Y; Fukasawa K; Nishikawa A; Kato Y
    Yakugaku Zasshi; 1980 Jul; 100(7):725-31. PubMed ID: 7205562
    [No Abstract]   [Full Text] [Related]  

  • 27. The binding of aurothiomalate to plasma proteins in vitro.
    Mason RW
    Pharmacology; 1977; 15(6):536-44. PubMed ID: 413121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
    Held H; Enderle C
    Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of non-linear plasma protein binding on unbound and total plasma phenylbutazone concentrations in cows.
    Boudinot FD; Williams RJ; Smith JA
    J Vet Pharmacol Ther; 1990 Jun; 13(2):132-6. PubMed ID: 2384903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding of salicylate to plasma protein from several animal species.
    Kucera JL; Bullock FJ
    J Pharm Pharmacol; 1969 May; 21(5):293-6. PubMed ID: 4390120
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of heparin injection on plasma protein binding of bilirubin and salicylate in rats.
    Wiegand UW; Levy G
    J Pharm Sci; 1979 Dec; 68(12):1483-6. PubMed ID: 529035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salicylate kinetics in old age.
    Netter P; Faure G; Regent MC; Procknal JA; Levy G
    Clin Pharmacol Ther; 1985 Jul; 38(1):6-11. PubMed ID: 4006377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of malnutrition. Part I. Salicylate binding studies using normal serum/plasma and kwashiorkor serum.
    Eyberg C; Moodley GP; Buchanan N
    S Afr Med J; 1974 Dec; 48(61):2564-7. PubMed ID: 4453937
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of certain drugs in the domesticated goat.
    Boulos BM; Jenkins WL; Davis LE
    Am J Vet Res; 1972 May; 33(5):943-52. PubMed ID: 5023053
    [No Abstract]   [Full Text] [Related]  

  • 38. Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.
    Wosilait WD
    Eur J Clin Pharmacol; 1976 Feb; 9(4):285-90. PubMed ID: 971712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1285-8. PubMed ID: 333094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of malnutrition on the pharmacokinetics of phenylbutazone.
    Krishnaswamy K; Ushasri V; Naidu NA
    Clin Pharmacokinet; 1981; 6(2):152-9. PubMed ID: 7214778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.